InquirerAeta communities in Bataan reject mining deal in ancestral landDaily MaverickAmazon’s Bezos says he helped pick Pattinson as BondThe Jerusalem PostSa’ar welcomes 250 US leaders for ‘50 States, One Israel’ initiativePunchNo evidence of Sokoto protest plot, DSS tackles Atiku20 MinutenWie weit ist ein Lichttag? Mach das Quiz zum Voyager-1-Rekord!한겨레‘리트 만점자’ 광수단·관악서 등에서 고발 이어져…수능 고득점 수사도 이뤄질 듯ZDF heuteAktuelle Pressemitteilungen des ZDFComplete SportsNNL: ‘It Will Be Disrespectful To Other Teams’ –Amuneke Speaks On Heartland’s NPFL Promotion HopesESPN CricinfoUnchanged England bat; Zampa out with back spasms for AustraliaNew Straits TimesAnwar thanks Trump for recognising Malaysia's role in easing Cambodia-Thailand tensionsLenta.ruГлава РФПИ назвал количество реализованных проектов с партнерами из АТЭСThe Japan TimesDemocracy needs room for religious difference
The Daily Newsstand · Free, Always
Wednesday, November 18, 2026

CytomX to receive $5M from Regeneron for cancer drug milestone

Translate
Male doctor visiting female cancer patient with care and compassion in hospital room. Oncology support medical consultation healthcare and hope. Doctor reporting medical test results to the patient

chanakon laorob

CytomX Therapeutics (CTMX) announced it will receive a $5 million payment after reaching a preclinical milestone in its cancer drug development partnership with Regeneron (REGN). CytomX shares rose 4.6% in extended trading Wednesday.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.